[go: up one dir, main page]

ATE279113T1 - HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDS - Google Patents

HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDS

Info

Publication number
ATE279113T1
ATE279113T1 AT00953925T AT00953925T ATE279113T1 AT E279113 T1 ATE279113 T1 AT E279113T1 AT 00953925 T AT00953925 T AT 00953925T AT 00953925 T AT00953925 T AT 00953925T AT E279113 T1 ATE279113 T1 AT E279113T1
Authority
AT
Austria
Prior art keywords
compounds
thiohypxanthine
hypoxanthine
inhibitors
formula
Prior art date
Application number
AT00953925T
Other languages
German (de)
Inventor
Mark Chasin
Peter Hofer
David Cavalla
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE279113T1 publication Critical patent/ATE279113T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36Sulfur atom
    • C07D473/38Sulfur atom attached in position 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Disclosed are compounds of formula (I) wherein R3, R6, R8 are as described herein. The compounds are effective selective PDE IV inhibitors.
AT00953925T 1999-08-12 2000-08-09 HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDS ATE279113T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14862399P 1999-08-12 1999-08-12
PCT/US2000/021836 WO2001011967A1 (en) 1999-08-12 2000-08-09 Novel hypoxanthine and thiohypoxanthine compounds

Publications (1)

Publication Number Publication Date
ATE279113T1 true ATE279113T1 (en) 2004-10-15

Family

ID=22526585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00953925T ATE279113T1 (en) 1999-08-12 2000-08-09 HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDS

Country Status (7)

Country Link
EP (1) EP1202628B1 (en)
JP (1) JP2003506467A (en)
AT (1) ATE279113T1 (en)
AU (1) AU6629000A (en)
CA (1) CA2379356A1 (en)
DE (1) DE60014915T2 (en)
WO (1) WO2001011967A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003037345A1 (en) * 2001-10-26 2003-05-08 Sciclone Pharmaceuticals, Inc. Pharmaceutical formulations comprising substituted xanthine compounds
AR039385A1 (en) 2002-04-19 2005-02-16 Astrazeneca Ab THIOXANTINE DERIVATIVES AS INHIBITORS OF MIELOPEROXIDASA
CN114588161A (en) * 2020-12-07 2022-06-07 四川大学华西医院 Hypoxlavine derivatives with prevention and treatment of pneumonia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL24642A (en) * 1965-11-18 1971-06-23 Rashi M Method for preparation of 6-thioxo purines from 6-methylthio purines
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
DE69531506T2 (en) * 1994-12-13 2004-06-24 Euroceltique S.A. ARYLTHIOXANTHINE
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
JP2002508378A (en) * 1997-12-12 2002-03-19 ユーロ−セルティーク,エス.エイ. Method for producing 3-substituted adenine and imidazopyridine

Also Published As

Publication number Publication date
EP1202628A4 (en) 2002-10-30
CA2379356A1 (en) 2001-02-22
DE60014915T2 (en) 2005-10-13
JP2003506467A (en) 2003-02-18
EP1202628A1 (en) 2002-05-08
EP1202628B1 (en) 2004-10-13
DE60014915D1 (en) 2004-11-18
WO2001011967A1 (en) 2001-02-22
AU6629000A (en) 2001-03-13

Similar Documents

Publication Publication Date Title
TR200002480T2 (en) Guanidine derivatives for the treatment of izazemi
DK1070056T3 (en) Phthalazinone PDE III / IV Inhibitors
DK1200412T3 (en) Antiproliferative imidazole compounds
TR200201505T2 (en) Pirazolopyrimidines as therapeutic agents
PT1206467E (en) N-HETEROCYCLIC DERIVATIVES AS US INHIBITORS
ATE302775T1 (en) CARBOLINE DERIVATIVES
ATE389635T1 (en) PHARMACEUTICALLY ACTIVE PIPERIDINE DERIVATIVES
ATE301653T1 (en) PYRAZOLOPYRIDINES
TR200302268T4 (en) N-heterocyclic derivatives useful as NOS inhibitors.
ATE300541T1 (en) PYRAZOLOPYRIDINE DERIVATIVES
ATE346067T1 (en) CARBOLINE DERIVATIVES
GB0308201D0 (en) Novel compounds
PE20030061A1 (en) 1-BIARIL-1,8-NAPHTHYRIDIN-4-ONA AS PHOSPHODIESTERASE-4 INHIBITORS
MXPA04006041A (en) Pyridoquinoxaline antivirals.
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
TR200201128T2 (en) Tetrahydrothiopyraniphalazinone derivatives as PDE4 inhibitors.
PT1109560E (en) USEFUL COMPOUNDS AS AICARFT INIDERS
NO20015892L (en) Inhibitors of metal proteinases
AU2001296699A1 (en) Condensed pyrazindione derivatives as pde inhibitors
DK1015437T3 (en) Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
DE60213798D1 (en) Carbolic derivatives as PDEV inhibitors
PL359409A1 (en) Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
ATE279113T1 (en) HYPOXANTHINE AND THIOHYPXANTHINE COMPOUNDS
SE9904128D0 (en) Novel compounds
ATE246174T1 (en) TOSYLPROLINE DERIVATIVES AS THYMIDYLATE SYNTHASE INHIBITORS

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties